Due to lack of awareness about the danger signs of pregnancy women fail to seek care in the right time for life-threatening complications of pregnancy and child birth. This cross-sectional study was undertaken to assess the knowledge regarding danger signs among pregnant women. A self structured questionnaire was used in the study. For this, 100 women attending antenatal outpatient department (OPD) were enrolled. Chi-square test has been used to demonstrate the difference between study subject characteristics and level of significance selected for this study (p. 0.05). About 6.38% of subjects having good awareness about danger signs are from age group 20 to 25 years and 10.25% of subjects with good awareness are from 25 to 30 years. In case of 20% of subjects have fair knowledge that means they know about 50 to 75% of obstetric danger signs while 73% of subject has poor knowledge about danger signs. Among which majority, i.e. 46.48% of subjects are from age 20 to 25 years and 93.33% from large family size have poor awareness about danger signs. Majority of subjects having good knowledge about obstetric danger signs have completed their secondary (7.69%) and university (9.52%) education. About 61% of the subjects know about danger signs of pregnancy. Among which major source of knowledge is health personnel (57.37%) and other source of knowledge is mass media (42.63%). In case of 50% of subjects knows about bleeding. Thus, it is the most common obstetrical danger sign that is known by subject population. How to cite this article Vijay NR, Kumare B, Yerlekar DS. Awareness of Obstetric Danger Signs among Pregnant Women in Tertiary Care Teaching Hospital. J South Asian Feder Obst Gynae 2015;7(3):171-175.
Bhavna Durgaprasad Kumare et al ABSTRACTThe acute and chronic management of paroxysmal supraventricular tachycardia (PSVT) during pregnancy presents a challenging clinical situation as there are no evidence-based guidelines despite being the commonest arrhythmia found in pregnancy. We report a case of paroxysmal supraventricular tachycardia in a 25 years old antenatal woman with no organic heart disease, where she received verapamil followed by diltiazem as antiarrhythmics instead of adenosine for conversion into sinus rhythm. Since she had recurrent episodes in third trimester she received verapamil and metoprolol as prophylaxis with good fetal and maternal outcome. This case highlights the need to understand the complexities in diagnosis and management of paroxysmal supraventricular tachycardia during pregnancy.
Leprosy is a rare event during pregnancy. A high index of suspicion is needed for prompt diagnosis, and a multidisciplinary approach is required for proper management. Multidrug therapy (MDT) is safe and effective during pregnancy and lactation. Hereby, we are reporting a case of lepromatous leprosy with erythema nodosum leprosum (type II lepra reaction) during the third trimester of pregnancy.
Red degeneration of leiomyoma is a rare type of degeneration. Hyaline, calcareous, and fatty degenerations are being more common. It is a medical enigma because of its peculiar and acute presentation associated with pregnancy. Red degeneration of fibroid is very rare in nonpregnant women. Although uncommon, a gynecologist should be aware of the entity for timely diagnosis and treatment. Here two cases of red degeneration in nonpregnant women are reported. In the first case, a woman was reported with menorrhagia, fever, pain, and urinary complaints. Red degeneration of fibroid was not suspected and, to utter surprise, the histopathology report was suggestive of red degeneration of fibroid. In the second case, a woman was presented with a lump and pain in the abdomen, and history of fever. On the basis of the previous experience, clinical diagnosis of red degeneration was considered. It was confirmed by histopathology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.